These results suggest that FASN, PLAUR, BCL2L1, HMOX1 and RHOB may participate in the anti-Anoikis process of CTEPH, which further aggravates the condition of patients with CTEPH, which is consistent with the results of our study. The gene discussed is PLAUR; the disease is chronic thromboembolic pulmonary hypertension.